MedTrace Logo

Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma

NCT06261658 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-02-15

No results posted yet for this study

Summary

The study is aimed to evaluate the effects of intraovarian injection of autologous Platelet-enriched Autologous Plasma on the outcomes of orthotopic transplantation of cryopreserved ovarian tissue.

Conditions

  • Cryopreservation
  • Ovary Injury
  • Infertility, Female
  • Menopause Ovarian Failure

Interventions

PROCEDURE

Cryopreserved Ovarian Tissue Reimplantation

Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Diego Raimondo, MD · IRCCS AOU Bologna

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-12-29
Completion
2033-12-29

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06261658 on ClinicalTrials.gov